Correlation Between Sinphar Pharmaceutical and Adimmune Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and Adimmune Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and Adimmune Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinphar Pharmaceutical Co and Adimmune Corp, you can compare the effects of market volatilities on Sinphar Pharmaceutical and Adimmune Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of Adimmune Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and Adimmune Corp.

Diversification Opportunities for Sinphar Pharmaceutical and Adimmune Corp

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Sinphar and Adimmune is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and Adimmune Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adimmune Corp and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with Adimmune Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adimmune Corp has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and Adimmune Corp go up and down completely randomly.

Pair Corralation between Sinphar Pharmaceutical and Adimmune Corp

Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to generate 1.01 times more return on investment than Adimmune Corp. However, Sinphar Pharmaceutical is 1.01 times more volatile than Adimmune Corp. It trades about -0.09 of its potential returns per unit of risk. Adimmune Corp is currently generating about -0.13 per unit of risk. If you would invest  3,725  in Sinphar Pharmaceutical Co on September 3, 2024 and sell it today you would lose (640.00) from holding Sinphar Pharmaceutical Co or give up 17.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Sinphar Pharmaceutical Co  vs.  Adimmune Corp

 Performance 
       Timeline  
Sinphar Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Adimmune Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adimmune Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Sinphar Pharmaceutical and Adimmune Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sinphar Pharmaceutical and Adimmune Corp

The main advantage of trading using opposite Sinphar Pharmaceutical and Adimmune Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, Adimmune Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adimmune Corp will offset losses from the drop in Adimmune Corp's long position.
The idea behind Sinphar Pharmaceutical Co and Adimmune Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like